A gene expression-based immune signature for lung adenocarcinoma prognosis.

Lijuan WangXizhi LuoChao ChengChristopher I AmosGuoshuai CaiFeifei Xiao

Published in: Cancer immunology, immunotherapy : CII (2020)

The identified DEG features may serve as potential biomarkers for prognosis prediction of LUAD patients and immunotherapy. Based on that assumption, we identified a gene expression-based immune signature for lung adenocarcinoma prognosis.

Keyphrases

gene expression
end stage renal disease
dna methylation
ejection fraction
newly diagnosed
chronic kidney disease
peritoneal dialysis
prognostic factors